Vol 13 No 1 (2019)

Published: 2019-01-14

Prognostic significance of aberrant CD5 expression in B-cell leukemia

Kaveh Jaseb, Daryush Purrahman, Saeid Shahrabi, Majid Ghanavat, Hadi Rezaeean, Najmaldin Saki

Prospects for repurposing CNS drugs for cancer treatment

Mohamed Abdelaleem, Hossam Ezzat, Muhammed Osama, Adel Megahed, Waleed Alaa, Ahmed Gaber, Ayman Shafei, Alaa Refaat

A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies

Abdul Aziz Mohamed Yusoff, Wan Salihah Wan Abdullah, Siti Zulaikha Nashwa Mohd Khair, Siti Muslihah Abd Radzak

Adherence to oral pharmacological treatment in cancer patients: Systematic review

Melissa Perdomo Claros, Claudia Viviana Marín Messa, Herney Andrés García-Perdomo

Advances in pancreatic cancer biomarkers

Syed Hasan, Rojymon Jacob, Upender Manne, Ravi Paluri

Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature

Vasilios Pergialiotis, Ioannis Bellos, Nikolaos Thomakos, Dimitrios Haidopoulos, Despina N. Perrea, Konstantinos Kontzoglou, Georgios Daskalakis, Alexandros Rodolakis

Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma

Shang-Yi Huang, Tsai-Yun Chen, Ching-Yuan Kuo, Yeu-Chin Chen, Sheng-Fung Lin, Ming-Chih Chang, Xinzhu Lv, Betty Yang, Cheng-Shyong Chang

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility

Mohammad Shahjahani, Elham Homaei Hadad, Shirin Azizidoost, Kowsar Chenani Nezhad, Saeid Shahrabi